JB
NBRV

Julian Baker’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Julian Baker’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,753
Closed -$3.27M – 120
2018
Q2 		$3.27M Hold
3,753
– – 0.02% 89
2018
Q1 		$4.72M Hold
3,753
– – 0.04% 77
2017
Q4 		$5.61M Hold
3,753
– – 0.05% 74
2017
Q3 		$7.68M Buy
3,753
+2,353
+168% +$5.52M 0.06% 61
2017
Q2 		$3.67M Hold
1,400
– – 0.03% 70
2017
Q1 		$4.2M Hold
1,400
– – 0.03% 69
2016
Q4 		$2.09M Hold
1,400
– – 0.02% 92
2016
Q3 		$2.47M Hold
1,400
– – 0.02% 90
2016
Q2 		$2.63M Hold
1,400
– – 0.03% 86
2016
Q1 		$3.14M Hold
1,400
– – 0.03% 86
2015
Q4 		$3.37M Hold
1,400
– – 0.03% 91
2015
Q3 		$3.33M Buy
+1,400
New +$3.71M 0.03% 87

Other funds holding NBRV

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

Julian Baker's NBRV Position: Q3 2018 in Review

Julian Baker sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2018, closing a stake of 3,753 shares — an estimated $3.27M sold.

Julian Baker first reported a position in NBRV in Q3 2015 and held it in 12 quarters. The position peaked at $7.68M in Q3 2017. 45 funds tracked by Wall St. Rank hold NBRV as of Q3 2018.

  • Julian Baker reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2018 after selling out during the quarter.
  • Julian Baker sold 3,753 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2018, an estimated $3.27M.
  • Julian Baker first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 12 quarters.
  • Julian Baker's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $7.68M in Q3 2017.
  • 45 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2018.

Based on Baker Bros. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.